MRFR@Press Releases

The report for Global Microbiology testing Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The Global Microbiology Testing Market has been evaluated as swiftly growing market and it is expected that the market will continue to grow similarly in the near future. Increasing prevalence of infectious diseases, changing disease pattern, and growing awareness are key driving forces for global microbiology testing market. Moreover, technological advancement, new techniques and methods, and changing medical sector, increasing funding for research is some factors leads the market growth. Microbiology Testing Market is expected to reach US$ 5409.1 million by 2023 and is projected to grow at a CAGR of 10.4% during the forecast period from 2017-2023. Major Players in Micro

The World Saliva Collection And Diagnostic Market Research Report provides detailed analysis of the key regional market status of the Healthcare Industry. The global Saliva Collection And Diagnostics Market is expected to grow at a CAGR of approximately 10.0%.Saliva is a perfect translational research tool and diagnostic medium which is being utilized as a part of novel approaches to give molecular biomarkers a variety of oral and systemic infections and conditions. The capacity to break down saliva to screen health conditions and diseases is an exceedingly alluring objective for oral health advancement and research. Saliva tests have been used to detect caries risk, periodontitis, breast cancer, oral cancer, salivary gland diseases, and systemic disorders such as hepatitis, HIV and HCV. Technological progress has permitted high level of studies to be performed at a scale which was unrealized previously and is serving to propel the discovery and approval of salivary disease biomar

Market Research Future.com add new report of “ Clinical Data Analytics Market Research Report – Global Forecast To 2022” it contains Company information, geographical data and Table of Content The Global Clinical Data Analytics Market Is Expected To Reach USD 11,853.6 Million By the end of the forecasted period and is expected to grow at a CAGR of 30.90%. Healthcare sector is taking innumerable approaches to address their analytical needs including claims and clinical data to provide quality of care to the patients. Clinical data analytics is a new approach which is shifting towards new payment models and the sheer amount of clinical data contained in Electronic Health Records (EHR). Nowadays, more and more healthcare professionals are looking towards analytics solutions for population management solutions.  Top key players in this Clinical Data Analytics Market are: Athenahealth Inc. (U.S.), Cerner (U.S.), International Business Machines Corporation (U.S.), McKesson (U.S.),

The market Research Future Published New Report “Wearable Sensors Market Research Report- Global Forecast To 2020” The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. Wearable sensors can be used in different sports and occasion. Wearable devices are gaining attention in research activities. Increasing adoption of different type of wearable devices in healthcare and fitness is one of the major driver of this market. With the miniaturization model and falling prices, more number of sensors are expected to be in use in the forecast period. These sensors are used in many of the different devices like watch, smart phones, VR headsets, jewelry and many more. The key factor for the growth of the market is small size, easy of handling and low cost. Motion sensors are the widely used type of wearable devices. A motion s

The Market Research Future provides detailed analysis of “ Global Uterine Fibroid Market Research Report – forecast till 2022” by type, by indication and by end user. The Worldwide Uterine Fibroid Market Research Report provides detailed analysis of the key regional market status of the Healthcare Industry. The Uterine Fibroids Market is expected to reach USD 39,993.2 Million by the end of the forecasted period and is expected to grow at a CAGR of 3.24%. Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman’s uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen. Increasing prevalence due to heredity and rising number of treatments to cure this disease has fuelled the growth of this market.   Key Players for U.S.  Uterine Fibroid M